Delivery Order SPE2DB24D8001-SPE2DB25FKYTL
Award Date
10/23/24
Potential Completion Date
10/24/24
Potential Value
$3.6K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA). The $2,393.98 fixed-price delivery order contract is for the supply of DIOVAN HCT 320-25 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 18, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract, valued at $6,169.79, is a Firm Fixed Price Delivery Order for the provision of DIOVAN HCT 160-25 MG TABLET 90S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This contract, which is part of the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $7,663.14, is for the delivery of DIOVAN HCT 320-25 MG TABLET 90S, a prescription medication. The contract has a firm fixed price and an ultimate completion date of May 13, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government,...
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBQKB, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,886.34, is for the delivery of Diovan HCT 160-25 mg tablets to support the DLA's Troop Support Medical division. This is a firm-fixed-price delivery order contract with a completion date of February 7, 2024. Dakota Drug, Inc. has also been awarded a larger...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $4,687.43, is for the delivery of Diovan HCT 320-25 mg tablets in quantities of 90 per bottle. This pharmaceutical product is used to treat hypertension. The contract has an ultimate completion date of June 18, 2024 and was awarded on...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4562910943 - DIOVAN HCT 160-25 MG TABLET 90S, a cardiovascular medication. The award has a ceiling value of $4,776.43 and runs through November 28, 2023. This award is under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Losartan-HCTZ 100-25 mg tablets. The contract has a ceiling value of $1,747.92 and a completion date of February 11, 2025. The contract is a firm fixed-price delivery order, which is not associated with a set-aside program. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare...
This federal contract award, valued at $30,166.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract is for the delivery of DIOVAN HCT 160-25 MG TABLET 90S, a pharmaceutical product, to support military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of Losartan-HCTZ 100-25 mg tablets. The contract has a firm fixed price of $22,937.69 and a period of performance through March 5, 2025. This award is not designated as a set-aside contract. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,807.32 firm fixed-price delivery order is for the supply of Losartan-HCTZ 100-12.5 mg tablets. This order is part of a larger $999,999,999.00 indefinite delivery contract (SPE2DB24D8001) held by Dakota Drug, Inc. under the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment,...